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ABSTRACT
Postural Orthostatic Tachycardia Syndrome (POTS):
A Primer for Nurse Practitioner Practice
Emily S. Richards
College of Nursing, BYU
Master of Science
Postural orthostatic tachycardia syndrome (POTS) is a form of orthostatic intolerance
(OI) that affects 0.2% of the population and is over-represented in women of childbearing age. It
is caused by autonomic dysfunction and hypovolemia that presents with marked tachycardia and
with minimal change in blood pressure upon standing. Orthostatic symptoms must be present
including: lightheadedness, nausea, chest pain, palpitations, shortness of breath, and nausea and
must improve with recumbence. The three main subtypes of POTS are neuropathic POTS
associated destruction of peripheral nerves and venous pooling, hypovolemic POTS associated
with low blood volume, and hyperadrenergic POTS associated with inappropriate sympathetic
activation. It is easily diagnosed by hemodynamic testing, but is difficult to treat. Treatment
involves increased fluid and salt intake, exercise, and pharmacologic measures. POTS is a
chronic illness that significantly affects quality of life. The purpose of this article is to describe
the clinical presentation, the underlying physiological and pathological processes involved, the
diagnostic criteria, and current management strategies for postural orthostatic tachycardia
syndrome (POTS).

Keywords: Postural orthostatic tachycardia syndrome (POTS), autonomic dysautonomia, near
syncope, non-neurogenic seizure
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Postural Orthostatic Tachycardia Syndrome (POTS): A Primer for NP Practice
Introduction
Postural Orthostatic Tachycardia Syndrome (POTS) affects an estimated 0.2% of the
population, yet it is relatively unknown to healthcare providers.1, 2 It predominantly affects
females (5:1) during the reproductive years between ages 14 and 50.1-5 While there have been no
known mortalities from POTS, it is a chronic, often severely debilitating condition.3
The defining features of POTS are pronounced tachycardia while standing without
hypotension causing significant symptoms which improve with recumbence. However, POTS is
associated many non-orthostatic symptoms as well.6, 7
Similar constellations of symptoms were recognized by DaCosta as early as the U.S.
Civil War; however, Schondorf and Low described the phenomenon and coined the term as
postural orthostatic tachycardia syndrome.7, 8 Little was understood about the cause of POTS in
1993, but it is now known to be a heterogenous syndrome with a common final pathway.2-4
Many different pathophysiological processes occur independently or together leading to POTS.
Its onset may be insidious and progressive, or it may occur suddenly after an illness or major
stress to the body.4, 9
It is not uncommon for patients with POTS to be misunderstood and misdiagnosed
initially, delaying appropriate treatment. The purpose of this article is to describe the clinical
presentation, the underlying physiological and pathological processes involved, the diagnostic
criteria, and current management strategies for postural orthostatic tachycardia syndrome
(POTS).
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Clinical Presentation
Case Study
S.P. is a 37-year-old female who collapsed while on vacation at an amusement park.
Before that morning, she functioned as business owner, mother, and socially-engaged
community member. At the moment of her collapse, she lost her ability to function. She was
unresponsive for two hours. She heard the noises around her and was aware of her surroundings,
but unable to lift her head or respond, she maintained some muscle control but was tremulous
during the episode. Over the next several months, similar episodes happened repeatedly. She had
severe orthostatic intolerance and standing for any length of time would elicit another episode of
near-syncope and tremulousness.
She was seen at the ED multiple times for evaluation of her symptoms and was admitted
for a video EEG to rule out a seizure disorder. The symptoms presented did not exactly match
multiple emergency conditions, but symptoms such as altered mental status, weakness,
tremulousness, chest pain and palpitations, shortness of breath, and abdominal pain mimicked
emergency conditions. The severity of the symptoms was not well-explained by her history. At
each ED visit medical staff were concerned that they were missing something and they
questioned whether this might be a psychiatric illness. The neurologist opined that S.P. had
psychogenic pseudoseizures, a manifestation of conversion disorder. This differential diagnosis
was enticing as it explained the symptoms well and especially accounted for the “nonneurogenic” seizures. One provider felt that S.P. fit the quintessential profile of a person with
conversion disorder: a woman in her reproductive years experiencing a trauma that was too great
for her mind to handle causing her body to respond by losing physical function. However, S.P.
did not have a history of significant trauma or sources of great unhappiness, shame, or guilt in
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her life. The provider had an answer in psychology and stopped looking for a better explanation
for her symptoms.
S.P. returned to her primary care provider who understood postural orthostatic
tachycardia syndrome (POTS) and he diagnosed her using a relatively uncomplicated and lowtech test. She was lucky; her diagnosis took less than a month.
History of Present Illness
Up to fifty percent of patients diagnosed with POTS had an identifiable antecedent event,
most often a viral illness; however, surgery, trauma, concussion, or pregnancy can also trigger
POTS. While the individual symptom profile varies, all must have orthostatic symptoms that
worsen with standing and improve with recumbence. The signs and symptoms of POTS reflect
central nervous system (CNS) hypoperfusion, autonomic nervous system (ANS) activation, and
underlying conditions.2
Orthostatic symptoms include lightheadness, near syncope, chest pain, palpitations,
blurred or tunnel vision, tremulousness, shortness of breath, nausea, and paresthesia. CNS
symptoms are often present, including impaired sleep, headache, mental clouding, depression,
and anxiety.2, 7 Cognitive symptoms often persist even when lying supine, which may be
indicative of unknown pathophysiologic effects of POTS on the central nervous system.10 Most
patients report extreme fatigue and a significant majority develop chronic pain.11
Other manifestations of systemic autonomic involvement include: gastroparesis,
abdominal pain, post-prandial bloating, constipation, poor thermoregulation, diaphoresis or
anhidrosis, increased urinary output or urinary retention, and weakness.4, 11 Symptoms are
exacerbated by heat, illness, dehydration, exercise, alcohol use, and menstruation. Symptoms are
worse in the morning.4 Physical signs may include acrocyanosis, hypermobility, impaired
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sweating, dermatologic changes, tremulousness, and altered attention, and cognitive processing.1,
4

Pathophysiology
Normal Physiology
Normally when a person stands, around 25% of the blood in the thoracic cavity is
displaced downward by gravity causing a significant drop in stroke volume; the body’s
compensatory mechanisms are extensive including sympathetic activation increasing heart rate
and vascular tone. When a person stands, the heart rate typically increases by 10 to 15 beats per
minute (bpm) and the diastolic blood pressure increases by approximately 10 points while the
systolic blood pressure is unchanged.3, 7
POTS Pathophysiology
With POTS an exaggerated fluid shift causes an exaggerated sympathetic response
causing the heart rate to increase more than 30 bpm (40 bpm in children and adolescents) while
maintaining a normal or elevated blood pressure. Defining POTS purely as a type of orthostatic
intolerance (OI) is inaccurate; rather, it is a disorder of the autonomic nervous system with
systemic effects. For this reason, many patients experience symptoms that are not directly related
to orthostatic intolerance. For nurse practitioners (NPs) unaware of the autonomic basis of
POTS, the constellation of symptoms creates an unclear diagnostic picture. The autonomic
nervous system is involved in all automatic processes in the body; therefore, patients with POTS
frequently have other symptoms of autonomic dysfunction including significant cognitive,
gastrointestinal, thermoregulatory, and other symptoms.4, 11
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Subtypes
The literature is unclear regarding the subtypes of POTS. There is a lack of consistency in
the classification of POTS. The literature generally refers to three subtypes of POTS:
neuropathic, hyperadrenergic, and hypovolemic. These subtypes address broader mechanisms
leading to orthostatic tachycardia. Each subtype has multiple associated causes and could be
classified with more specificity; however, there is no uniformity in the literature regarding
further classification. POTS can be primary if idiopathic or secondary if there is a known
underlying cause. Identification of underlying processes is essential in the effective treatment of
POTS.12 A patient with POTS may have multiple subtypes reflecting the causes of their
symptoms. Additionally, there is no ICD-10 code specific for POTS. Some practitioners use a
code related to autonomic dysfunction, others may classify it as orthostatic hypotension, or as
other specified cardiac arrhythmia.13
Neuropathic POTS affects up to 50% of patients with POTS. It is caused by loss of nerve
fibers usually of small and distal postganglionic fibers in the lower extremities, especially in the
feet and toes. There is an inability of the distal vasculature to constrict leading to venous pooling
evident by acrocyanosis. Those with neuropathic POTS frequently have abnormalities with the
sudomotor fibers as well affecting thermoregulation and may have decreased sweat production.2,
4, 5

Hyperadrenergic POTS is caused by an overactive sympathetic nervous system (SNS).
People with adrenergic POTS will have increased norepinephrine levels (>600 pg/ml) with
orthostasis; they may have normal or increased levels of norepinephrine when supine.
Autonomic storms cause hypertension, tachycardia, and diaphoresis independent of orthostatis.
Patients with hyperadrenergic POTS are prone to greater symptom burden related to SNS
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activation, such as increased tremulousness (sometimes referred to as pseudoseizures),
anxiety/panic symptoms, and palpitations.
Approximately 70% of patients with POTS have hypovolemic POTS.3 Research shows
that patients with hypovolemic POTS have low blood plasma volume and decreased RBC
count.2, 4 Many have abnormalities in the renin angiotensin aldosterone system with decreased
renin and aldosterone response to changes in blood and stroke volume and decreased metabolism
of angiotensin II.2, 4, 5
Many other conditions and processes contribute to the presentation of POTS. Some
processes that have been shown to be involved in subsets of patients with POTS include
autoimmunity to α1, β1, or β2 adrenergic receptors, mast cell activation disorders, poor vascular
tone caused by Ehlers Danlos Syndrome (hypermobility type), and NET transporter protein
deficiency.2-4, 14 Chronic fatigue syndrome (CFS), concussion, migraine, celiac disease, and IBS
are frequently comorbid with POTS and may contribute to the presentation. POTS is often
associated with autoimmune disorders—especially Sjőgren’s disorder, systemic lupus
erythematus (SLE), and Hashimoto thyroiditis. 3, 4, 14. When there are known comorbidities,
treatment of the comorbidities tends to improve POTS symptoms.12
Diagnosis
To be diagnosed with POTS, a patient must have an increase of heart rate on standing at
least 30 bpm (40 bpm in adolescents) or have a standing heart rate of >120 bpm and have
orthostatic symptoms that improve with recumbence. The patient should have had symptoms for
at least six months; though in some cases, acute onset is adequately severe as to warrant
diagnosis.2, 3, 7
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The primary diagnostic test is orthostatic vital signs with a prolonged standing evaluation
at two, five, and ten minutes; if the patient is unable to tolerate standing, the evaluation can
include a head up tilt test (HUT) using a tilt table.3, 7, 14 Cardiac causes should first be ruled out
by ECG, and if needed: holter monitor, echocardiogram, and stress test. Tachycardia in POTS is
sinus tachycardia. Laboratory testing should include a CBC, CMP, and TSH.3, 4
Other diagnostics identify underlying causes, comorbidities, and the subtypes of POTS
and should guide treatment. Further laboratory testing may include supine and upright serum
metanephrine levels, 24-hour urine, A1C, Vitamin B12 levels, ANA, viral and bacterial
screenings, and enzyme and hormone levels. Symptoms may warrant further infectious,
autoimmune, autonomic, gastrointestinal, genitourinary, cognitive/psychological, and sleep
studies.3, 4 Common differential diagnoses include: anemia, thyrotoxicosis, inappropriate sinus
tachycardia and other cardiomyopathies, adrenal insufficiency, pheochromocytoma, panic
disorder, paraneoplastic syndrome, and amyloidosis.4, 5
Prognosis
Much of the early literature indicates that full recovery is quite common and downplays
the chronic nature of the disorder.3, 5, 11 While some patients experience a complete resolution of
symptoms, most will see significant improvement within the five years of diagnosis, but others
may require at least non-pharmacologic treatment throughout their lives.1, 2, 5, 15
The level of impairment and the effect of POTS on quality of life can be quite significant.
Results of a study by Pederson and Brook showed that patients with POTS have more days with
poor health, more extreme fatigue and low energy, activity limitations, and poorer sleep than
controls; they were also at much higher risk for suicide.16 Approximately 25% of patients with
POTS are unable to work.1, 6
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Management
Non-pharmacological treatment creates a solid foundation for positive outcomes by
expanding blood volume and venous return. This base is essential for effective treatment of
POTS. The main components of non-pharmacological treatment include: 1) increased fluid and
sodium intake, 2) a graded aerobic exercise program, 3) use of compression garments, 4) trigger
avoidance, and 5) physical countermeasures. Fluid and electrolyte supplementation, exercise, and
the use of compression garments are discussed below.
For some non-pharmacological treatment is enough; however, frequently
pharmacological treatment is needed. Raj, Opie, and Arnold propose that cognitive behavioral
therapy (CBT) can help patients adjust to life with a debilitating chronic illness.10 If possible
multidisciplinary treatment approach is best and may include both physical/occupational therapy
and mental health services.2, 10
Non-Pharmacological Management
Increased fluid and sodium intake. Because patients with POTS tend to have a lower
total blood volume, it is recommended that they consume at least 2to 3 liters of fluid per day. To
keep fluid in the intravascular space, it is important to increase sodium intake to as much as 10 to
12 grams.2 To achieve this, most require salt supplementation using salt tablets. Increasing salt in
the diet also increases thirst and aids with fluid consumption.12, 17
Intravenous fluids can significantly improve symptoms; however, the Heart Rhythm
Society’ 2015 consensus statement recommends that intravenous fluids be used as a rescue effort
in acute decompensation, and not as a chronic treatment.12, 17 18
Exercise. Exercise is the most important and challenging element of treatment. It requires
frequent contact with a provider to work through the difficulties during the acute phase of illness.
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Fu, et al. described a reconditioning exercise protocol in detail in their 2010 article on the cardiac
origins of POTS.19 A similar exercise regimen with more specifics was outlined the Children’s
Hospital of Philadelphia (CHOP). It can be accessed at:
https://www.dysautonomiainternational.org/pdf/CHOP_Modified_Dallas_POTS_Exercise_Progr
am.pdf
A person with acute exacerbation of POTS should start with fully recumbent exercises.
Fu, et al. described the Patients should exercise at regular intervals, generally every other day.17
Exercising too much can exacerbate symptoms. Patients can void symptom exacerbation by
using a heart rate monitor to ensure their heart rate stays within the defined moderate intensity
exercise levels (usually between 140-150 bpm), using solely recumbent exercise modalities at
first to decrease orthostatic symptoms, increasing the minutes gradually, and having appropriate
intervals for rest, both during exercise and between sessions.
Compression garments. Waist high, medium compression garments (at least 30 mmHg)
are recommended to help prevent fluid pooling in the lower extremities. If needed, an abdominal
binder can limit splanchnic pooling, manifest by a feeling of abdominal fullness.7
Pharmacological Treatment
Medications are used to treat the underlying pathophysiological dysfunction. Medications
target low blood volume, tachycardia, peripheral vasoconstriction, and sympathetic activation.
Providers can prescribe medications to treat the most problematic symptoms of POTS, such as
mental clouding, insomnia, constipation, tremulousness, and fatigue. Treating comorbid
autoimmune disorders, infections, and chronic pain disorders in addition to treating the vascular
mechanisms and symptoms associated with POTS improves outcomes.

10
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Due to lack of clinical trials and large randomized control studies, most evidence for
pharmacological treatment comes from small studies. Because the physiologic mechanisms of
POTS vary significantly among patients, the effect of medications on the treatment of POTS
varies as well. Both fludrocortisone and midodrine can be effective in increasing blood volume.
Midodrine is very short-acting and is given three times a day, but can cause supine hypertension,
so it is only given during waking hours. Generally, propranolol in low doses (10-20 mg TID)
improves tachycardia and symptomology of POTS but may increase fatigue.12, 14
For patients with hyperadrenergic POTS, clonidine and alpha-methyldopa can decrease
central sympathetic activation, but the CNS effects of fatigue, drowsiness, and slowed cognition
can be problematic. Pyridostigmine increases the acetylcholine available in autonomic ganglia
and in the muscarinic synapses in the heart—improving tachycardia and symptoms of POTS—
but the GI and urinary side effects are often not tolerated well.2, 12 Ivabradine, a medication new
to market in the United States, has shown promise in trials in Europe by decreasing tachycardia
and improving symptoms of POTS by affecting the “funny” sodium channels of the sinus node.2,
12, 20

Pharmacological treatment is a balancing act and patients with POTS tend to be more

sensitive to the intended and unintended effects of medications.18
Appendix A lists important medications in the management of POTS and helpful
prescribing guidelines presented previously in Practical Neurology and used with permission of
the authors.
Discussion
It is not uncommon to find a provider who has never heard of POTS or one who
questions its validity as a medical diagnosis. However, there is strong evidence and sufficient
research legitimizing POTS as a physiologic syndrome with distinct pathophysiology affecting
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both the autonomic nervous and cardiovascular system. It is neither a psychiatric diagnosis nor
simply a functional diagnosis. Hypervigilance with physical sensations and anxiety frequently
coexist with symptoms of POTS, but they do not cause POTS.2 A delayed diagnosis of POTS
often leads to an initial misdiagnosis of a psychiatric disorder. Patients with POTS frequently
have mild to moderate depression and subclinical anxiety, but psychiatric disorders are found
with similar prevalence in patients with POTS as in the general population.1, 10
Patients with POTS are high utilizers of healthcare due to the impact of their symptoms
on quality of life and the similarity of their symptoms to emergency conditions. On average a
patient with POTS sees an average of seven providers and takes four years to receive a correct
diagnosis. Over 25% see more than ten providers before receiving a correct diagnosis.1 As NPs
become more aware of the clinical manifestations of POTS, the time to diagnosis would be
expected to decrease significantly.
When NPs are aware of and understand POTS, it is relatively easy to diagnose, but it is
difficult to treat. Significant provider time and support is required to develop an effective
treatment plan. Additionally, it may take several medication trials to find a regimen that works.
While some patients experience great progress quickly and are back to a functional level within
months, for most, this is a chronic illness that impacts every aspect of their quality of life. Early
diagnosis and treatment can halt the deconditioning that occurs over time with POTS and can
make the path to recovery a little less steep.
It would make sense to refer this patient to a special given the complexities of the clinical
course and the intricacies of treatment, but there are too few specialists in POTS.1 And which
specialist should the NP refer to? While this is primarily a neurological disorder, the key
symptomology lies squarely in the territory of cardiology. There are interdisciplinary specialty
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clinics for POTS and other autonomic disorders scattered throughout the country, but as of 2018,
only approximately 40 physicians were board certified in Autonomic Disorders in the United
States.1 Patients frequently wait months for an appointment with a provider with experience in
treating POTS; therefore, NPs must become well-versed in the diagnosis and treatment of POTS.
Conclusion
POTS is a highly relevant syndrome that significantly impacts patients’ lives—much
more prevalent than would be expected from a syndrome that no one has ever heard of before.
Articles about POTS and autonomic disorders historically have been found in journals for
cardiovascular and autonomic disorders. They are rarely found in the literature for nurse
practitioners. As more articles about POTS appear in literature for NPs, awareness and
understanding of POTS will improve. Continued research will yield greater understanding of the
pathophysiology of POTS and will lead to better treatment outcomes. The body of knowledge is
growing, and it will be essential to stay up to date to effectively treat individuals with POTS.
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Appendix A
Table 1
Medications in Treatment of POTS. Used with Permission of the Authors.
Medication

Dose

Mechanism of
Action
β-adrenergic receptor
antagonist

Side Effects

Notes

Propranolol

10-20 mg orally
four times a day

Bradycardia,
bronchospasm
and hypotension

2.5-10 mg orally
every 4 hours of
TID

α-1 adrenergic
receptor agonist

Fludrocortisone

0.05-0.2 mg/day
orally or every
other day

Pyridostigmine

30-60 mg orally
TID

Expands blood
volume through renal
reabsorption of
sodium
Acetylcholinesterase
inhibitor

Scalp
paresthesia,
piloerection,
urinary retention
and supine
hypertension
Hypertension,
hypokalemia,
and edema

May help in
lower doses and
is not well
tolerated in
higher doses
Do not take 4
hours before
bedtime to avoid
supine
hypotension

Midodrine

Clonidine

0.05-0.2 mg BID

Central sympatholytic
α-2 receptor agonist

Methyldopa

125-250 mg orally
BID

Desmopressin
(DDAVP)

0.2 mg orally as
needed

Central sympatholytic
(false
neurotransmitter)
Acute blood volume
expansion

Ivabradine

5-7.5 mg qd or bid

Funny channel
blocker

Modafinil

100 mg orally
twice daily

Stimulant

Diarrhea and
abdominal
cramping
May cause
sedation and
hypotension
Sedation and
hypotension
Water retention
and
hyponatremia
Bradycardia
May exacerbate
tachycardia in
some patients

Monitor for low
serum potassium
It helps but is not
too potent by
itself
Decreases plasma
norepinephrine;
can lead to
rebound due to
short half-life
Longer half-life,
so often better
tolerated
Carefully monitor
for hyponatremia.
No randomized
trials for pots
Approved for
sleep disorders,
but may help
with
concentration in
POTS

Medications commonly used to treat the symptoms of postural tachycardia syndrome (POTS). These
medications can be used alone or in combination.
Jones, PK, et al. Practical Neurology 2016: 16:431-438. Doi:10.1126/practneurol-2016-00140514

